Keywords
Pancreatic cancer, Endoscopic ultrasound, Hepatobiliary diseases, COVID-19
Disciplines
Medicine and Health Sciences
Abstract
Introduction
While rapid on-site evaluation (ROSE) is considered to be an additional tool to optimize the yield of tissue acquisition during EUS-guided FNA of the gastrointestinal tract,1,2 it is not readily available at all times while performing these procedures.
Methods
We reviewed twenty-seven EUS-guided FNA procedures done at our institution in Tripoli central hospital with general working center restrictions due to local COVID-19 prevention protocols. This is a small-size retrospective chart review study to illustrate the optimal tissue adequacy during EUS-guided FNA of the upper gastrointestinal tract in a suboptimal hospital setting, lack of ROSE and merely utilizing visual inspection of those specimens by the performing physician and its effects on the diagnosis.
Results
Approximately 92.6 % of tissue adequacy was achieved despite the lack of ROSE which is comparable to ROSE-based tissue acquisition results.
Conclusion
We concluded that our results of tissue acquisition and analysis with the standard (off-site) histopathology techniques are comparable to those in more developed centers where ROSE is readily available.
Recommended Citation
Hammad M, Alwifati N, Ajala M,
et al.
Can the conventional cytology technique be sufficient in a center lacking ROSE?: Retrospective study during the COVID-19 pandemic.
Marshall J Med.
2021;
7(2): 77
DOI: https://doi.org/10.33470/2379-9536.1315.
